Merck's KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery | Region
RAHWAY, N.J.--(BUSINESS WIRE)--Oct 5, 2023--
Stay updated with breaking news from Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RAHWAY, N.J.--(BUSINESS WIRE)--Oct 5, 2023--
Reaffirms Guidance for Third Quarter and Fiscal Year 2023ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Wayde McMillan has decided to step down from his role as...
Organizations can now bolster their talent pool instantly by leveraging their alumni workforce
Merck has added new lots of Banamine to their previous recall.
/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the Pre-IND meeting requested on September...